Study details
Enrolling now
Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2)
University of Nebraska
NCT IDNCT05070013ClinicalTrials.gov data as of Apr 2026
Target enrollment
20
Study length
about 4.6 years
Ages
18–80
Locations
2 sites in NE, PA
About this study
This trial is testing whether adaptive stimulation of the Subthalamic Nucleus (STN) can improve sleep quality and maintenance in people with Parkinson's disease. Participants will receive deep brain stimulation treatments, alternating between stimulation and no stimulation, to see if it affects their sleep patterns.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Deep Brain Stimulation
Primary goalSubjective Sleep Quality
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Subjective Sleep Quality
Devices
implantable
Body systems
Neurology